The bone marrow provides a framework of micro environmental domains or niches that support the function of immune cells and haematopoietic stem cells (HSCs). Cellular niches are functional compartments within tissues that control cell numbers by providing signals that regulate cell selfrenewal, differentiation and quiescence
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. Such signals can be transmitted via direct cell contact, growth factors and cytokines, or components of the extracellular matrix. The concept of bone marrow cellular niches was first formulated as a hypothesis more than 30 years ago 2 , and our understanding of these niches is based in part on the study of model organisms such as Caenorhabditis elegans and Drosophila melanogaster, as well as on the study of other mammalian tissues, such as the intestine and the epidermis 3 . Our goal in under standing how HSCs and immune cells process signals from their niche is to develop novel cellular therapies that enhance immune function or haematopoietic recon stitution after injury, or that assist in the treatment of haematological malignancies and autoimmune diseases.
Knowledge about niche components has been obtained through three main types of experiments. First, factors that modulate HSC and immune cell behaviour have been isolated, both in vitro and in vivo (TABLE 1) . Second, conventional or intravital microscopy has been used to define the relationship of HSCs and immune cells with their surrounding niche components. Third, genetic mouse models or drug treatments have been used to study the changes in HSC and immune cell function in response to specific alterations in different components of the niche (TABLE 2) .
It is important to note that niches in higher organ isms are unlikely to be created by a single cell type, but are a tissue -that is, a combinatorial interaction of cells, matrix, biophysical forces and metabolic substrate components. Studies that define a contributing cell type should not be interpreted as indicating that this cell type is the niche. In addition, because the haemato poietic and immune systems need to rapidly respond and adapt to the needs of the organism, their niche within the bone marrow should not be viewed as a static entity, but rather as a microenvironment that continually processes and conveys information. These aspects lead to challenges and controversies in understanding how various cell types generate the niche in vivo.
In this Review, we aim to dissect the individual com ponents of the haematopoietic and immune cell niches in the bone marrow, and build on this knowledge to discuss how these elements collaborate to form a functional sys tem. We begin by reviewing the various components of the haematopoietic and immune cell niches. Recent stud ies focusing on perfusion, oxygenation and innervation highlight how the bone marrow is divided into distinct domains. Against this background, we discuss how HSCs and immune cells respond to particular situations -such as inflammation or the depletion of mature progenitors -by integrating the signals provided by their niche.
Haematopoietic stem cell niches
HSCs arise in a sequential manner during embry onic development. They are first found in extra embryonic tissues and are subsequently present in the aorta-gonad-mesonephros area, then in the fetal liver and spleen, and finally in the bone marrow, which is the major haematopoietic organ in adults 4 . The HSCs can be enriched from the bone marrow cell pool on the basis of the expression of specific cellsurface markers. One such cell population is characterized as lineage markernegative SCA1   +   KIT   +   CD41   -CD48   -CD150   + , and these cells are referred to as LSK SLAM cells. One in two cells in this population are functional HSCs, and thus LSK SLAM cells are often used as a representative HSC population in flow cytometry or microscopy studies 5 . In the steady state, microscopy studies of the bone marrow have identified LSK SLAM cells in the periphery of sinusoids, near endosteal surfaces and in the poorly defined 'stroma' that is located between the sinusoids 5 , suggest ing that HSCs can reside in multiple locations (FIG. 1) . We describe below the known contributions of different bone marrow cell types to the regulation of HSCs.
It is important to note that, although most HSCs in adults are present in the bone marrow, this may not be an absolute requirement for their function, as haematopoie sis can also occur in extramedullary sites (for example, in the spleen, liver and lungs) 6 . The spleen in rodents is a welldefined site where HSCs can function. It is less clear whether the same is true in humans, although under stress conditions some degree of haemato poiesis is observed in the spleen and other sites. Whether extramedullary sites provide comparable regulation, particularly of stem cell quiescence, is debated, but evi dence suggests that the bone marrow may be distinct from the spleen in that regard 7 .
A defining feature of a niche is the ability to regu late the selfrenewal of stem cells, but the precise links between HSC selfrenewal and location have not yet been well defined. It has been shown that modulating osteo blastic cell function can increase haematopoietic stem and progenitor cell (HSPC) numbers, but whether it does so by direct or indirect action is not clear 8 . Therefore, our knowledge to date provides a picture of bone marrow niches with only a limited resolution.
Vascular contribution to the niche. Multiple indirect lines of evidence suggest that areas adjacent to blood vessels constitute an HSC niche. First, the generation of HSCs occurs in association with vascular areas and blood flow during embryonic development [9] [10] [11] . Second, in humans, extramedullary haematopoiesis occurs in perivascular areas in the setting of haematopoietic stress 6 . Third, HSCs (as defined by their immuno phenotype) have been observed in the vicinity of sinusoids 5 . Last, endothelial cells have been shown to express cellsurface molecules that facilitate the transit of HSCs and immune cells between the bone marrow and the periphery 12 . APRIL, a proliferation-inducing ligand; BAFF, B cell activating factor; CAR, CXCL12-abundant reticular; CXCL12, CXC-chemokine ligand 12; DKK1, dickkopf-related protein 1; HSC, haematopoietic stem cell; IL, interleukin; MIF, macrophage inhibitory factor; MSC, mesenchymal stromal cell; SCF, stem cell factor.
Adventitial cells
Connective tissue cells that surround small blood vessels and have a supportive structural role and possibly other functions, such as blood flow regulation.
On the basis of in vivo and ex vivo studies, bone mar row endothelial cells were found to express factors that promote haematopoiesis, such as granulocyte colony stimulating factor (GCSF), granulocyte-macrophage colonystimulating factor (GMCSF), macro phage colonystimulating factor (MCSF), stem cell factor (SCF; also known as KIT ligand), interleukin6 (IL6) and FMSrelated tyrosine kinase 3 ligand (FLT3L; also known as FLK2 ligand) 13 . In addition, these cells were shown to express the adhesion molecules Eselectin, Pselectin, vascular cell adhesion molecule 1 (VCAM1) and intercellular adhesion molecule 1 (ICAM1) 14 . The bone marrow vasculature is heterogeneous in its expression of molecules that are thought to facilitate cell homing, such as Eselectin and CXCchemokine ligand 12 (CXCL12). Such homing pathways can also be exploited by malignancies that can metastasize to the bone marrow 12, 15, 16 . In vitro, immortalized endothe lial cells can support HSC function in culture through the expression of Notch ligands 17 . Similarly, the expres sion of a constitutively active mutant form of AKT in endothelial cells (using a cellspecific inducible transgenic mouse model) leads to an increase in HSC numbers 18 . These characteristics support the idea that endothelial cells can provide niche functions in vivo, although conclusive evidence that they do so is not yet in hand.
Mesenchymal contribution to the niche. Endothelial cells are surrounded by perivascular mesenchymal stromal cells (MSCs), which provide structural support and harbour populations of cells that can regenerate 19 or the cyto plasmic fila ment protein nestin in mice 20 can give rise to ectopic haematopoietic microenvironments following trans plantation, suggesting that these cells are involved in the regeneration of the bone marrow stroma. These cells wrap around blood vessels and adrenergic nerve fibres, both in the central and endosteal bone marrow regions, and they express several proteins that regulate HSC maintenance, including CXCL12, angiopoietin 1 and SCF. Deletion of nestinexpressing MSCs leads to a 50% reduction in bone marrow HSC numbers and a proportional increase in HSC numbers in the spleen, suggesting that nestinexpressing cells are involved in tethering HSCs in a perivascular location within the bone marrow 20 . CXCL12abundant reticular (CAR) cells are a sub population of mesenchymal cells that were identified in a genetic mouse model in which green fluorescent protein (GFP) was expressed under the control of the Cxcl12 promoter 21 . CAR cells are scattered throughout the bone marrow, secrete factors that support haemato poiesis, and are located adjacent to a substantial proportion of immuno phenotypically defined HSCs. The deletion of CAR cells in the adult mouse using a suicidegene strategy leads to a decrease in HSC numbers and an increase in HSC quiescence 22 . As the aforementioned nestinexpressing MSCs also express high levels of CXCL12, nestinexpressing MSCs might represent a functional subtype of CAR cells that are found in the peri vascular location. Distinct functions for the various types of mesenchymal cell populations are in the pro cess of being defined. For example, recent data suggest that moreprimitive mesenchymal cells, such as those expressing nestin, are participants in HSC regulation 20 . Adipocytes are another stromal component of the bone marrow microenvironment that is thought to regulate HSC function. In mice, the adipocyterich tail vertebrae have markedly fewer HSPCs and less cell cycling than the adipocytepoor thoracic vertebrae 23 . In a lipoatrophic genetic mouse model, bone marrow trans plantation led to accelerated haematopoietic recovery following irradiation compared with recovery times in control mice, although alterations in osteogenesis were also present in this model and a possible confounder of the adipocytespecific effects 23 . Likewise, blood vessels in the bone marrow are often in close association with bone, although their interaction is still poorly understood (d). At the endosteal surface, osteoblastic cells express factors that participate in HSC retention; osteoclasts regulate osteoblastic cell function by inducing bone remodelling; and macrophages regulate osteoblastic cell activity and the retention of HSCs. In the bone marrow stroma, HSCs are associated with CAR cells, which express factors that promote HSC retention. Adipocytes negatively regulate HSCs in the steady state. In the perivascular area, HSCs are associated with nestin-expressing cells, which promote HSC retention and are regulated by macrophages and the sympathetic nervous system (SNS).
Trabecular bone
A network of bony projections that is present at the ends of long bones and forms a highly vascularized, porous matrix that is the main site of haematopoiesis in adults.
Osterix
(Also known as SP7). A zinc finger-containing transcription factor that is required for the commitment of mesenchymal cells to the osteoblastic lineage.
Dicer1
This gene encodes Dicer, an endoribonuclease that cleaves double-stranded RNA and is important for processing pre-microRNAs.
Epigenetic changes
Modifications in the activation state of certain genes that persist following cell division. These alterations are not related to changes in DNA sequence, but are induced through other mechanisms, such as DNA methylation and histone modifications. (TABLE 2) . Likewise, supraphysiological activation of osteoblastic cells using lineagespecific expression of a constitutively active parathyroid hormone receptor leads to expansion of the HSC pool 8 . Modification of the function of osteoprogenitors, which are defined by osterix expression, also appears to affect the integrity of haematopoiesis and the cycling of HSCs 34 . Finally, con ditional depletion of osteoblasts markedly compromises GCSFmediated mobilization of HSCs from the bone marrow 35 . Together, these data provide a strong case for the participation of cells of the osteolineage in the HSC niche.
Although osteolineage cells are participants in the niche, it is not true that all cells of the lineage have a role. The data indicate that it is moreprimitive osteolineage cells rather than mature osteoblasts that provide niche functions. A study in which Dicer1 was deleted in osteo progenitors identified alterations in multiple parameters of haematopoiesis, including HSC cycling, whereas the same gene deletion in mature osteoblasts had no such effect 34 . Others have also found that immature osteo lineage cells have a more prominent role 36 . Therefore, there appears to be a complex and hierarchical organi zation of nichemodulating functions among different mesenchymal cell types.
The products of osteolineage cells have also been shown to modulate HSC function in vivo. For example, osteoblasts secrete the extracellular matrix protein osteo pontin, which regulates HSC numbers and migration to the endosteal surface 37, 38 . Furthermore, osteolineage cells lay down an extracellular matrix that becomes highly mineralized, and this creates a high Ca 2+ concentration at the periendosteal surface. HSCs respond to Ca 2+ via the calciumsensing receptor, and this process is required for their engraftment in the bone marrow 39 .
Osteoblasts are responsible for inducing the matura tion of osteoclasts through the production of receptor activator of NFκB ligand (RANKL), and this molecule may participate in regulating HSCs. Acute activation of osteoclasts following RANKLmediated stimulation leads to haematopoietic progenitor cell proliferation and mobi lization 40 , whereas the suppression of osteoclast activity by pharmacological methods decreases HSC numbers in the bone marrow 41 and increases HSC mobilization 42 . However, genetic mouse models with altered osteoclast numbers have provided conflicting results regarding the effects on HSC mobilization 42, 40 . These results suggest that osteoclasts may have some role in maintaining the numbers of HSCs in the bone marrow, but their role in mobilization is still in question.
Trabecular and mesenchymal niche components include macrophages, as deletion of these cells in vivo leads to HSC mobilization through a decrease in the expression of HSC retention factors by nestinexpress ing cells 43 and perhaps by osteoblasts 44, 45 . GCSFinduced HSC mobilization appears to exert an inhibitory action on macrophages, and this in turn modulates HSC localization through effects on other niche popula tions [43] [44] [45] . Therefore, macrophages are participants in the modulation of HSC localization.
Immune cell niches Through celldeletion and microscopy studies, several subsets of bone marrow cells have been shown to sup port immune cell function. Indeed, in addition to its role as a primary lymphoid organ through the support of lymphoid development, the bone marrow can act as a host for various mature lymphoid cell types.
HSC commitment to lymphopoiesis. Lymphoid devel opment is a highly ordered process that is accompanied by the sequential expression of different growth factor receptors and cellsurface molecules. Deciphering the factors that instruct HSCs to adopt a lymphoid fate and the isolation of cellular intermediates in the process of lymphoid commitment are active areas of research. Several groups have demonstrated heterogeneity in the lymphoid reconstitution potential among HSCs, sug gesting that some HSCs possess an intrinsically deter mined lymphoid bias [46] [47] [48] . Whether this bias results from epigenetic changes programmed by interactions with the niche is unknown. The HSC bias is skewed towards myelopoiesis during ageing 48, 49 , but likewise it is unclear whether this is due to the accumulation of genetic changes in HSCs or an alteration in niche elements.
Niches for lymphopoiesis. Early in lymphoid develop ment, multipotent progenitors with T cell potential migrate to the thymus, while progenitors with B cell potential remain in the bone marrow. Signalling through the Notch receptor has been shown to direct lineage specification towards a T cell fate (reviewed in REF. 50 ), but whether 'priming' of early thymic progeni tors occurs in the bone marrow before migration to the thymus is still unknown. The bone marrow niches for B cell development are better understood. Through celldeletion studies and microscopy, the sequen tial engagement of multiple niches has been shown to contribute to B cell development within the bone marrow. Osteoblasts, osteoclasts and CAR cells are required for the earliest stages of development, whereas IL7secreting stromal cells and sinusoidal endothelial cells promote further B cell maturation (FIG. 2a,b,c) . Osteoblast ablation using expression of a suicide gene under the control of the type I collagen α1 promoter results in a rapid and dramatic decrease in the numbers 
T cell-independent antigens
Antigens that do not require T cell help to induce specific antibody production. These antigens are commonly polymeric antigens, such as polysaccharides and lipids.
Splenic marginal zone
An area in the spleen with the major function of trapping circulating antigens. The marginal zone is populated by a distinct population of lymphocytes that can be readily activated following exposure to blood-borne pathogens.
of preproB cells and proB cells 51 . By contrast, inhi bition of osteoclast function leads to relocalization of B cell progenitors to the spleen, presumably through a compensatory decrease in osteoblast function 52 , and this suggests that the endosteal surface is required for the initial steps in B cell lymphopoiesis.
CAR cells are found in close association with pre proB cells 53 , and their ablation leads to a decrease in the numbers of common lymphoid progenitors and proB cells, suggesting that CXCL12 expression is required for tethering early B cell progenitors in the bone marrow 22 . The transition from preproB cells to proB cells requires IL7 signalling 54 , and IL7secreting stromal cells (which do not express CXCL12) are found in proximity to proB cells, suggesting that they constitute a distinctive niche 53 . In addition, as part of their matura tion, most B cells migrate to peripheral organs; however, some B cells remain in contact with sinusoidal endothelial cells. This adhesion is mediated in part by VCAM1 and endocannabinoid receptor expression, and it contributes to the diversity of the immunoglobulin repertoire through an unknown mechanism 55 . Finally, although most newly formed B cells continue their maturation in the spleen at this point, the bone marrow can also support the development of a small proportion of functional mature B cells 56 .
Collectively, these studies demonstrate that B cell lymphopoiesis is dependent on the successful engagement of multiple cellular niches in the bone marrow.
Niches for naive immune cells. The bone marrow peri sinusoidal space is populated by clusters of dendritic cells (DCs) that colocalize with naive recirculating B cells and T cells 57, 58 (FIG. 2d) . Deletion of these DCs using a suicide gene strategy led to a decrease in the number of naive B cells in the bone marrow, as well as a decrease in IgM secretion following immunization, whereas B cell pro genitors and T cells were not affected. These DCs are thought to provide naive B cells with specific survival signals, such as macrophage migration inhibitory factor (MIF) 57 . Interestingly, perisinusoidal naive B cells can be activated by T cell-independent antigens, in a manner similar to that which occurs in the splenic marginal zone. Regarding T cells, the factors required for their mainte nance in the bone marrow are less well understood, but perisinusoidal DCs can also crosspresent bloodborne antigens to naive T cells 58 . Collectively, this suggests that immune cells localized in perivascular regions in the bone marrow provide key functions that are important for protection against bloodborne pathogens.
Niches for plasma cells. Following antigen exposure, B cells can home back to the bone marrow, where they persist as antibodysecreting plasma cells 59 . In vitro and in vivo studies have shown that plasma cells depend on survival signals from their microenvironment, and these signals include CXCL12, IL6, CD44, B cellactivating factor (BAFF) and a proliferationinducing ligand (APRIL) 60, 61 . Plasma cells are found in close proximity to CAR cells 53 , and mice genetically deficient in CXC chemokine receptor 4 (CXCR4) show impaired homing of plasmablasts 62 , demonstrating that the engraftment of plasma cells requires CXCL12 signalling via CXCR4. Two other mature cell types, eosinophils and megakaryo cytes, contribute to the plasma cell niche. Eosinophils secrete APRIL, a member of the tumour necrosis fac tor (TNF) superfamily, and their depletion leads to a decrease in the numbers of bone marrow plasma cells 63 . Megakaryocytes also secrete APRIL and IL6, and mice deficient in megakaryocytes have lower plasma cell numbers 64 . Interestingly, CAR cells express low levels of APRIL but can recruit eosinophils and megakaryocytes through the secretion of CXCL12 (REFS 65, 66) . Thus, CAR cells might act as 'core organizers' of the plasma cell niche by coordinating the action of multiple cell components (FIG. 2f) .
Niches for memory cells. Several studies have found that the bone marrow harbours a substantial population of memory immune cells. In mice, following shortterm antigen challenge, the majority of longlived CD4 + T cells localize to the bone marrow, where they reside in close contact with IL7secreting stromal cells 67 (FIG. 2e) . Furthermore, these cells can be quickly activated follow ing secondary challenge to provide efficient helper func tions, qualifying them as bona fide memory CD4 + T cells. The majority of bone marrow CD4 + memory T cells are in the G0 phase of the cell cycle, and interaction with IL7secreting stromal cells has been proposed to main tain this quiescence in the absence of antigen receptor signalling 67, 68 . Experiments using adoptive transfer of central memory CD8 + T cells that were differentiated in vitro demonstrated that these cells can also home to the bone marrow and respond to antigen stimulation 69 . This suggests that the bone marrow has a role in the maintenance of both CD4 + and CD8 + memory T cells. In addition, in a mouse transplantation model, allo geneic HSCs are protected against allorejection by host regulatory T (T Reg ) cells that reside within the bone mar row; these two cell populations are found in close proxim ity at the endosteal surface, and deletion of T Reg cells leads to allorejection 70 . This study raises the possibility that T Reg cells share the same niche as HSCs and contribute to making this an immuneprivileged site.
Niches for myeloid immune cells.
The earliest recog nizable myeloid precursors are found adjacent to the endosteal surface and small blood vessels 71 , suggest ing that they reside in specific niches. Although these niches are not fully characterized, ablation of CAR cells leads to accelerated myeloid differentiation, suggesting that CAR cells maintain HSPCs in an undifferentiated state 22 . At baseline, the bone marrow constitutes a res ervoir for mature myeloid elements; the release of these myeloid cells into the peripheral blood is mediated by specific ligands. Neutrophils and monocytes express chemokine receptors that antagonistically regulate their egress into the peripheral blood. In the steady state, both cell types express CXCR4, which promotes their reten tion into the bone marrow through CXCL12induced signalling. In the setting of inflammation, CXCR2 mediates the release of neutrophils through interaction with CXCL1 and CXCL2 produced by megakaryo cytes 72, 73 , whereas CCchemokine receptor 2 (CCR2) mediates the release of monocytes through interaction with CCchemokine ligand 2 (CCL2) produced by CAR cells, nestinexpressing MSCs and endothelial cells 74 . Collectively, these studies demonstrate that, in addi tion to its role as a primary lymphoid organ, the bone marrow has five other functions. First, it supports distinct populations of naive B cells and T cells in a perivascu lar DC network. Second, it supports antibodysecreting plasma cells. Third, it supports memory immune cells. Fourth, it serves as an immuneprivileged site for HSCs. And, fifth, it serves as a reservoir of myeloid immune cells.
Functional organization of the bone marrow
At present, the quest to construct a model of HSC and immune cell niches is quite unidimensional, as it is based on the interpretation of experiments in which a single molecule or a single cell is manipulated, and this inter pretation is limited by the lack of an interactive map. Mapping interactions might provide predictive algorithms for how alterations in each component can modulate changes throughout the system. Overcoming this limita tion is possible by accumulating information about spe cific cell types and responses to individual changes. It can also be facilitated by adding another dimension to the model by including factors that inherently integrate inputs from the organism as a whole (such as innervation or vas cular perfusion) or factors that influence cell state (such as metabolic substrates, including oxygen). Combining these parameters under different conditions may ulti mately permit a less fragmented, more physiological and predictive portrait of bone marrow regulatory niches.
Perfusion. In mice, the systemic infusion of dyes that label cells to an extent proportional to their degree of perfusion allows the measurement of how blood flow relates to cell state (FIG. 3a) . Two studies have described the relationship between the extent of perfusion and the presence of HSCs 75, 76 . In both studies, the perfu sion dye Hoechst 33342 was injected intravenously and bone marrow cells were harvested shortly thereafter. Although the first study showed that the leastperfused fraction is enriched in HSPCs by 90 to 200fold com pared with the mostperfused fraction, it did not use specific cellsurface markers to clearly define whether stem cells were more abundant in the leastperfused region 75 . The second study found that half of the HSCs defined by the LSK SLAM markers reside in the least perfused area, a fraction substantially higher than that of other bone marrow cell types 76 . These data provide an interesting and suggestive association between HSCs and low perfusion, but it is not clear whether the levels of oxygen or other substrates in these regions are differ ent. Furthermore, it is not clear whether HSCs prefer entially localize to lowperfusion zones or whether their primitive cell state is better preserved in that context.
The state of immune cell niches has not yet been stud ied with perfusion dyes. The observations that naive B and T cells are close to sinusoids does not provide sufficient evidence, as flow in these vascular beds may be slow and not associated with high nutrient and gas exchange. It is therefore unclear whether the localization of immune subsets corresponds to low or high perfusion regions.
Oxygenation. Cell residence in a hypoperfused envi ronment might offer several advantages, including an increased concentration of locally secreted growth fac tors, protection from systemically distributed toxins and reduced generation of reactive oxygen species 77 . The hypoxiaspecific stain pimonidazole has been perfused to define the oxygenation of haematopoietic cells in vivo 78 . A substantial proportion of LSK SLAM cells were observed in regions with low levels of oxygen (FIG. 3b) . Several studies suggest that hypoxia is a negative regula tor of the cell cycle in haematopoietic cells. In vitro, HSCs are better maintained in hypoxic culture conditions, pos sibly owing to lower cycling rates 79, 80 . In vivo, inducible deletion of hypoxiainducible factor 1α (Hif1a) in HSCs leads to decreased quiescence and a better reconstitu tion ability in primary recipients, but this potential is exhausted in secondary transplantations owing to cellular senescence 78 . HIF1α is known to regulate the expression levels of key metabolic enzymes that favour lactic acid fermentation over mitochondrial respiration 81 . In sup port of this model, HSCs have a distinct metabolic profile characterized by low mitochondrial activity 82 . As a result, HSC residence in a hypoxic niche coupled with low mito chondrial activity might serve as a protective mechanism against oxidative damage.
Hypoxia also modulates the expression of soluble mediators and cytokines, as well as that of their recep tors. HIF1α activity in haematopoietic progenitors leads to the secretion of vascular endothelial growth factor (VEGF) 83 , a regulator of stem cell function 84 . Additional pathways -such as those mediated by KIT, Notch 1 and βcatenin -have been associated with HIF1α in other cell types 85, 86 , and it is possible that these pathways are similarly active in HSC maintenance. Finally, niche components are also responsive to hypoxia: endothe lial cells and MSCs react by expressing CXCL12, which facilitates the homing of HSCs 87 ; and osteoblasts react by secreting VEGF, which stimulates bone formation and angiogenesis 88 . Thus, hypoxia might be an impor tant step in the ontogeny of cellular niches within the bone marrow.
Factors other than hypoxia have also been shown to act upstream of HIF1α. In vitro, the cytokines SCF 89 and thrombopoietin 83 can increase HIF1α levels, possi bly through protein stabilization. MEIS1, a crucial tran scription factor for stem cell selfrenewal, binds to the Hif1a promoter and increases its expression 82 . Finally, forkhead box O3A (FOXO3A), a regulator of stem cell activity, induces the expression of CBP/p300interacting transactivator 2 (CITED2), a repressor of HIF1α activity 90 .
HIF1α activity has been less well studied in the adaptive immune system, but HIF1α has an important role in B cell lymphopoiesis. Ablation of HIF1α in the immune system impairs the transition from proB cell to preB cell, owing to the downregulation of the glycolytic pathway in highly proliferating late proB cells 91 , and leads to autoantibody production through an unclear mechanism 92 . It remains to be shown whether HIF1α is induced by a hypoxic niche or by other factors known to affect lymphopoiesis, such as insulinlike growth factor 1 (IGF1) 93 .
Innervation. The bone marrow is innervated by auto nomic and sensory nerves. Within the bone marrow, nerve fibres travel along the same path as the arterial blood supply and interact with perivascular mesenchymal cells and bonelining osteoblasts and osteoclasts 94 (FIG. 3c) .
MSCs express β2 and β3adrenergic receptors and medi ate HSC egress in response to acute variations in sympa thetic nervous system (SNS) tone 95 . Osteoblasts express only the β2 receptor and regulate their own growth, as well as osteoclast activity, in response to SNS signalling 96 . It has long been recognized that acute physiological stress leads to the rapid mobilization of bone marrow haematopoietic progenitors and splenic lymphocytes. In addition, circadian fluctuations in SNS tone corre late with the release of haematopoietic progenitors into the peripheral blood, as increased SNS tone induces the downregulation of CXCL12 expression by MSCs 95 . In vivo, nestinexpressing MSCs are closely associ ated with nerve fibres and with HSCs, making them putative gatekeepers for the SNSmediated release of The three panels show representative images obtained using techniques that can be applied to study perfusion, oxygenation and innervation of the bone marrow compartment and to highlight its heterogeneity. a | Study of the perfusion state of nucleated cells in the mouse bone marrow. Bone marrow was harvested 10 minutes after intravenous administration of Hoechst 33342 dye and fluorescence intensity was measured by flow cytometry. Different populations are defined according to the percentile of fluorescence intensity and can later be studied by immunophenotype or functional assays. b | Study of the oxygenation state in the mouse bone marrow. Hypoxic regions within femur sections were stained using pimonidazole and imaged 3 hours after intravenous pimonidazole injection. Pimonidazole is identified by a fluorescein isothiocyanate (FITC)-labelled pimonidazole-specific monoclonal IgG1 antibody (green), and the nuclei are visualized using 4ʹ,6-diamidino-2-phenylindole (DAPI) staining (blue). Images were acquired by confocal laser scanning microscopy using an X10 objective. The staining is heterogeneous and present both at the endosteal surface and at other locations, but the image is two-dimensional and therefore anatomical relationships are of limited precision. c | Study of the innervation of the mouse bone marrow. Whole-mount staining of the skull bone marrow revealed subendothelial nestin-expressing mesenchymal stromal cells that are innervated by sympathetic fibres. The projection stack (of depth ~100 μm) of fluorescent images shows the distribution of cells that express a nestin-GFP (green fluorescent protein) conjugate (green), as well as that of vascular endothelial cells that express CD31 (also known as PECAM1) (blue) and of sympathetic nerve fibres that express tyrosine hydroxylase (red). Nature Reviews | Immunology . The existence of a gap junction signalling pathway in MSCs that leads to coordinated CXCL12 secretion also raises the possibility that SNSderived sig nals can rapidly propagate in the bone marrow stroma 97 .
Physiologically, SNS tone variations may have a role in two aspects of progenitor egress. First, the SNS may reg ulate the release of progenitors during periods of acute stress; and, second, it may be involved in the homeostatic recycling of a small fraction of cellular niches on a daily basis, by inducing the periodic egress of HSCs.
Adrenergic stimulation of the cellular niches has an important role in the clinical use of supraphysiological doses of GCSF for stem cell mobilization. Mice defi cient in ceramide UDPgalactosyltransferase (CGT; also known as UGT8) display aberrant nerve conduc tion and almost no stem cell mobilization 98 . This pheno type is replicated in mice treated with the dopaminergic neuro toxin 6hydroxydopamine and in mice that can not synthesize noradrenaline owing to a lack of dopa mine βhydroxylase 98 . Interestingly, this phenotype is rescued by coadministration of GCSF and clenbuterol, a β2adrenergic agonist, highlighting the collaboration between these two signals 98 . The nature of the coopera tion between the two signals is still unclear and is an area of ongoing research (reviewed in detail in REF. 99 ).
In addition, HSCs can respond to sympathetic nervous stimulation in a cellautonomous manner. Human CD34 + CD38 -progenitor cells express dopamin ergic receptors, and in vitro treatment with agonists for these receptors increases the chemotaxis, proliferation and engraftment capacity of these progenitor cells in vivo 100 . These effects are only present when cells are pretreated with the mobilizing cytokine GCSF, and are abrogated by treatment with a dopamine antagonist. Cells of the innate and adaptive immune systems also respond to adrenergic stimulation 101 , suggesting that the SNS can modulate the behaviour of both HSCs and immune cells.
The responsiveness of cell niches
HSCs and immune cells need to rapidly adapt to the fluctuating requirements of the organism by generating progenitor cells and effector cells, respectively, while maintaining a reserve of cells for future challenges. In order to do so, these cells need to integrate signals from their environment. In this section, we discuss the vari ous adaptations of the bone marrow microenvironment that allow it to 'sense' the numbers of progenitors and respond to particular states of injury and inflammation.
Feedback mechanisms. HSCs have the ability to alternate between quiescence and the cell cycle according to exter nal cues. Indeed, treatment with cytotoxic agents (such as 5fluorouracil) leads to a depletion of actively cycling cells, and this is followed by the entry of quiescent HSCs into the cell cycle in an effort to restore homeostasis 102 . How quiescent HSCs 'sense' the need to enter the cell cycle is still poorly understood, but this could be medi ated by the loss of the inhibitory signals that were pro vided by the progenitors or by the concomitant injury of the niche and resulting alterations in the extrinsic cues that are detected by HSCs (FIG. 4) . A better understand ing of the mechanisms involved could yield considerable therapeutic benefit, as chemotherapy, radiation injury and invasion of the niche by malignancies are likely to alter HSC-niche interactions.
It is possible that HSCs and their progeny compete for soluble signals or niche occupancy. For example, depletion of DCs using a suicidegene strategy leads to myeloproliferation associated with increased serum levels of the cytokine FLT3L 103 ; the receptor for FLT3L is present on both haematopoietic progenitors and DCs, and this suggests that mature DCs can regulate the pro liferation of progenitors by controlling FLT3L levels. In aged mice, depletion of mature B cells enhances B cell lymphopoiesis 104 , suggesting that the accumulation of mature B cells during ageing initiates a negative feedback loop. Furthermore, in this study, the recovery of B cell numbers was accelerated after each round of depletion, indicating that HSCs and/or their niche might acquire reinforced programmes for B cell lymphopoiesis in this setting. Collectively, these studies suggest that extrin sic cues -including the relative abundance of other haematopoietic cell types -affect HSC proliferation and differentiation.
The role of niche occupancy and competition between HSCs for the niche remains a controversial area. It is a widely held notion that death or clearance of exist ing, nicheoccupying HSCs is required for transplanted cells to engraft. However, parabiosis experiments suggest that HSCs leave the niche with sufficient frequency to enable a turnover of engrafted cells of approximately 1% over 3 weeks 105, 106 . This calculation is based on the non physiological context of parabiosis, but it is validated by studies in which HSCs were intermittently infused into nonconditioned hosts 107 . These data indicate that there is ongoing entry and egress of HSCs to and from the niche. It is not clear whether this is due to an HSC intrinsic 'offrate' from the niche or to remodelling of the niche itself by processing mechanisms, such as bone turnover. However, the occurrence of this bone turn over supports the idea that HSCs are regularly challenged with the necessity of finding a new niche. This process is inherently one in which HSC fitness is tested and selection pressures may be exerted.
It has been observed by many researchers that increasing the number of HSCs infused in an experi mental transplant context does not result in a satura tion of engraftment. That is, there does not seem to be a point at which there is no longer additional engraft ment, although the slope of the line reflecting the number of cells engrafted compared with the number infused may flatten. These intriguing observations have suggested that HSCs may have some capacity to induce their own niche, a phenomenon observed in other model systems 108 . The notion that HSCs are not simply passive occupants of a preformed niche but participants in the construction of their own home is an appealing means of potentially explaining how extramedullary haemato poiesis can be established. This idea might also account for why leukaemic cells that are dependent on the bone marrow may have an expanded niche.
Effects of inflammation on cell niches. Information on tissue injury and infection is transmitted to the bone mar row through the systemic release of proinflammatory mediators. Within the bone marrow, the overall response to inflammation is geared towards the generation and egress of effector cells, although the type of response can vary according to the nature of the insult 109 . In a mouse model of mycobacterial infection, increased lev els of interferonγ (IFNγ) in the bone marrow lead to increased cycling and mobilization of HSPCs, and these features are accompanied by a decreased repopulation capacity in secondary recipients 110 . HSPCs possess a functional IFNγ response pathway, and thus can respond directly to proinflammatory signals. Likewise, HSPCs have been shown to proliferate in response to IFNα in a cellautonomous manner 111 .
The bone marrow microenvironment also has the ability to respond to injury and infection. GCSF, which is secreted in the context of inflammation, disrupts an important retention signal in the bone marrow: the CXCL12-CXCR4 axis 112 . GCSF also induces the expres sion of thymopoietin in the bone marrow, and this leads to the secretion of CXCR2 ligands by megakaryocytes, resulting in the mobilization of neutrophils 73 . In addition, stimulation of Tolllike receptors on CAR cells, nestin expressing MSCs and endothelial cells by microbial molecules leads to the secretion of CCL2, which induces the egress of monocytes into the peripheral blood 113 . Additional data on the topic have been obtained mostly through in vitro studies that must be interpreted with caution. Ex vivopurified MSCs have the ability to either suppress or stimulate immune responses. Once exposed to proinflammatory cytokines, MSCs can suppress lymphocyte proliferation through direct cell contact and secreted mediators 114 . In addition, ex vivo stimulation of MSCs with IFNγ can allow these cells to present soluble antigens to effector T cells by upregu lating the expression of MHC class I and MHC class II molecules 115 . However, whether these phenomena occur in vivo remains to be demonstrated. Endothelial cells can also respond to proinflammatory signals by modulating haemostasis, cell adhesion and vascular permeability 116 . Nevertheless, it is still unclear which signalling pathways are induced by inflammation in bone marrow endothelial cells, and whether they specifically modulate HSC or immune cell behaviour in this context. Collectively, these data support the hypothesis that the bone marrow stroma has a multi faceted response to inflammation that modulates HSC and immune cell behaviour.
Perspectives
The ability to rationally manipulate the haematopoietic and immune systems therapeutically requires insight into the dialogue between haematopoietic cells and their niches. Several questions remain unanswered. What are the minimal requirements for HSC selfrenewal? In which cellular compartment(s) does this selfrenewal mainly occur? Do HSCs compete for the niche in a clas sical sense, whereby cell death is imposed on 'loser' cells? How do niches form and regenerate, are they generated in response to haematopoietic cells themselves and what determines the number of niches? How do memory immune cells compete for space within their niches? As experimentally induced niche dysfunction can pre dispose an animal to myeloproliferative disease 24, 117 or myelodysplasia and cancer 34 , are human haematological or immune diseases caused by acquired niche abnormal ities? Are malignancies that localize to the bone marrow dependent on niche signals, and do those signals affect tumour responses to chemotherapy? Do HSCs com pete with leukaemic cells for the same niche? Answers to these questions have clinical potential, as interven ing at the interfaces of cells may be possible using bio logical or smallmolecule drugs, thereby providing new therapeutic opportunities for stem cell transplantation, immunemediated diseases and cancer
. 
